Evaluation of Fluconazole treatment effects on acute biliary pancreatitis

copmarsion of treatment effects with and without the use of Fluconazole on acute biliary pancreatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013082714333N3

Enrollment

Registered

2013-09-23

Start date

2013-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary acute pancreatitis. biliary acute pancreatitis

Interventions

Intervention 1: routine treatment (included Restriction of oral intake, correction of water and electrolyte, pain management intravenous fluids and, monitoring of central venous pressure, urine output

Treatment - Drugs

routine treatment (included Restriction of oral intake, correction of water and electrolyte, pain management intravenous fluids and, monitoring of central venous pressure, urine output controls the pr

Fluconazole is added to the treatment regimen for five days in the intervention group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria:patients consists of those who have been diagnosed with acute biliary pancreatitis based on clinical; laboratory and ultrasound results.criteria excluded: Pregnant women; patients with a history of previous hypersensitivity to fluconazole to mention; person that any allergies or suffer from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of disease. Timepoint: at starting point and six months later. Method of measurement: Based on Ratson criteria and CT. Scan.;Necessity to operation. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospita. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospital. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Costs of disease. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Treatments. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Complications. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Mortality rate. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.	—

Measure

Time frame

Severity of disease. Timepoint: at starting point and six months later. Method of measurement: Based on Ratson criteria and CT. Scan.;Necessity to operation. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospita. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospital. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Costs of disease. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Treatments. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Complications. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Mortality rate. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.

—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026